ストックスクリーナーアプリを入手
1.35
1.46%
-0.02
Curis Inc (CRIS) 最新ニュース
Curis (CRIS) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark for This Review; Stock Move: The Stock Gains 1.18% in the Latest SessionAnnual Financial Report - dars.gov.et
Curis (CRIS) Results Versus Estimates: EPS Falls Short of Its Estimate in Latest Trading; Trading Move: Shares Finish 5.56% Down in the Current UpdateEarnings Deceleration Risk - vinanet.vn
Curis Inc (CRIS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Curis (CRIS) Price Update: Slides 5.56% to $1.70; Boundary Check: the $1.61 to $1.78 Range Remains in Focus for the Current SessionDark Pool Volume - vinanet.vn
CRIS Reiterated by HC Wainwright & Co. -- Price Target Maintained at $43 - GuruFocus
Curis announces pricing of $5.6M public offering - TipRanks
CRIS Stock Price, Quote & Chart - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks - TipRanks
CRIS Q1 2026 Earnings: EPS Misses by 206.37% as Stock Slides 3.74%Profit Growth Outlook - vinanet.vn
Curis Inc. (CRIS) Slips 3.74% to $1.80: Key Support and Resistance Levels in FocusFear Greed Extreme - vinanet.vn
Curis Stock Price Forecast. Should You Buy CRIS? - StockInvest.us
Curis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Curis: Q2 Earnings Snapshot - AOL.com
CURIS INC 10-Q Summary: Revenue $0 Net income ($8.58M), EPS ($4.02) — 10-Q Summary - TradingView
Curis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Curis Prices $5.6 Million Public Offering With Healthcare-Focused Institutional Investors - marketscreener.com
CRIS Looks 91.8% Undervalued on GF Value™ Amid Unprofitability C - GuruFocus
Curis prices $5.6 million public offering at $1.50 per share By Investing.com - Investing.com Canada
Curis prices $5.6 million public offering at $1.50 per share - Investing.com
Curis, Inc. Announces Pricing of $5.6 Million Public Offering - PR Newswire
CURIS INC SEC Filing (Aug 13, 2026) - Stock Titan
Curis prices USD 5.6 million public offering at USD 1.5 per share with warrants - Bitget
IPO Databook: Curis (CRIS US)Aug 2026 - smartkarma.com
Curis (CRIS) seeks cash via best-efforts stock and warrant offering amid going-concern risk - Stock Titan
Curis Inc (CRIS) Stock News Today - TradingKey
Curis Inc expected to post a loss of $7.84 a shareEarnings Preview - TradingView
Curis Inc (CRIS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Curis, Inc. (CRIS) stock price, news, quote and history - au.finance.yahoo.com
Curis (CRIS) Stock Fair Value Moves Lower After Emavusertib TakeAim Model Rework - finance.yahoo.com
Primer: Curis Inc (CRIS US)Aug 2026 - Smartkarma
CRIS Q1 2026 Earnings: Deep EPS Miss Highlights Clinical-Stage HeadwindsPositive Surprise Momentum - vinanet.vn
CRIS Q1 2026 Earnings: Severe EPS Miss at -25 vs. -8.16 Estimate Signals Deepening Clinical-Stage Losses - vinanet.vn
Curis Inc expected to post a loss of $7.47 a shareEarnings Preview - TradingView
Curis Regains Nasdaq Compliance, Faces One-Year Monitoring - TipRanks
Curis doses first five patients in leukemia drug study - Investing.com
JonesTrading Maintains Curis(CRIS.US) With Buy Rating, Cuts Target Price to $20 - moomoo.com
CRIS|Curis Inc|Price:1.700|Chg%:-0.100 - TradingKey
Curis Inc. (CRIS) Gains 3.11% as Stock Tests Key Resistance Near $5.23Backspread Trade - vinanet.vn
Curis Inc (CRIS) Institutional Confidence - TradingKey
Curis Inc (CRIS) Cash Flow - TradingKey
Curis Inc (CRIS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus - Yahoo Finance
Curis Inc (CRIS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CRIS|Curis Inc|Price:5.190|Chg%:+0.300 - TradingKey
CRIS|Curis Inc|Price:1.670|Chg%:-0.030 - TradingKey
CRIS|Curis Inc|Price:1.836|Chg%:+0.166 - TradingKey
Curis Inc (CRIS) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Curis Inc (CRIS) Income Statement - TradingKey
Curis Inc (CRIS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Curis Inc (CRIS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Curis Inc (CRIS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CRIS Maintained by HC Wainwright & Co. -- Price Target Raised to $43.00 - GuruFocus
Curis, Inc. Revenue Breakdown – NASDAQ:CRIS - TradingView
CRIS Q1 2026 Earnings: Significant Earnings Miss Amid Broader ConcernsRevenue Per Share - dars.gov.et
CRIS Q2'26 Earnings: revenue estimate is 1.00M USD - TradingView
Curis stock jumps 11% on positive emavusertib trial data - Investing.com
Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates - Benzinga
Curis (CRIS) Stock Sees Fair Value Lift As Analysts Back Leadership And Consumer Focus - Yahoo Finance
Curis Q2 2026: Updated Clinical Data for Emavusertib Trials - grafa.com
Curis stock jumps 11% on positive emavusertib trial data By Investing.com - Investing.com South Africa
Curis Inc Positive Emavusertib Update Transcript - GuruFocus
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):